Wallachbeth capital announces pricing of bioaffinity technologies $2.5 million registered direct offering and concurrent private placement

Jersey city, n.j. , march 6, 2024 /prnewswire/ -- wallachbeth capital llc, a leading provider of capital markets and institutional execution services, announced today that bioaffinity technologies (nasdaq: biaf; biafw) has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered direct offering and common warrants to purchase up to 1,600,000 shares of common stock in a concurrent private placement (together with the registered direct offering, the "offering") at a combined purchase price of $1.5625 per common share.
BIAF Ratings Summary
BIAF Quant Ranking